Since sarcoidosis is a rare disease, it can be hard for patients to find a support system who understands what they are going through. For that reason, FSR started a Stop Sarcoidosis support group on Inspire, a health and wellness-focused online community. Patients...
Sarcoidosis is difficult to treat for many reasons. Mainly, there is not one clear way to treat sarcoidosis because it manifests in many forms and the cause is unknown. For this reason, there are also many ways to diagnose sarcoidosis, making it a diagnosis of...
(Jan. 9, 2020) — The ATS Foundation Research Program/Foundation for Sarcoidosis has awarded Nicholas Arger, MD, of the University of California, San Francisco a $80,000 Foundation Partner grant. The ATS Foundation Partner Grant provides crucial support to...
FSR has partnered with aTyr Pharma, Inc. to help inform patients about an ongoing clinical trial for ATYR1923, a potential new treatment for pulmonary sarcoidosis (ATYR1923-C-002, NCT03824392.) aTyr recently issued a press release, republished with permission below,...